We are live on
!
Find out more
VRM
Vectors Research Management Portfolio holdings
AUM
$383M
1-Year Est. Return
30.23%
This Fund
S&P 500
This Quarter
Est. Return
+1.22%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
–
AUM
$326M
AUM Growth
-$28.3M
(-8%)
Cap. Flow
-$29.3M
Cap. Flow
% of AUM
-8.98%
Top 10 Holdings %
Top 10 Hldgs %
39.51%
Holding
136
New
4
Increased
26
Reduced
74
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$2M |
| 2 |
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
+$1.73M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.19M |
| 4 |
Digital Realty Trust
DLR
|
+$841K |
| 5 |
Cheniere Energy
LNG
|
+$795K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$7.76M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$4.79M |
| 3 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$3.55M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$2.83M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$2.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.56% |
| 2 | Industrials | 5.5% |
| 3 | Energy | 5.44% |
| 4 | Healthcare | 5.44% |
| 5 | Financials | 3.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Broadcom
AVGO
$1.85T
| $201K | 0.06% |
+1,250
| New | +$175K |
|
127
Procter & Gamble
PG
$336B
| $200K | 0.06% |
1,213
-40
| -3% | -$6.54K |
|
128
AGCO
AGCO
$7.15B
| – | – |
-4,201
| Closed | -$517K |
|
129
CF Industries
CF
$19.2B
| – | – |
-6,880
| Closed | -$573K |
|
130
Walt Disney
DIS
$167B
| – | – |
-1,664
| Closed | -$204K |
|
131
DexCom
DXCM
$31.5B
| – | – |
-12,422
| Closed | -$1.72M |
|
132
Gilead Sciences
GILD
$162B
| – | – |
-9,189
| Closed | -$673K |
|
133
State Street SPDR S&P Bank ETF
KBE
$1.64B
| – | – |
-5,290
| Closed | -$249K |
|
134
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| – | – |
-5,626
| Closed | -$283K |
|
135
Regeneron Pharmaceuticals
REGN
$78.5B
| – | – |
-1,025
| Closed | -$987K |
|
136
CVR Partners
UAN
$1.36B
| – | – |
-5,132
| Closed | -$403K |
|
Similar funds
RC
DSA
MVP
RSS
STP
DR
DFA
PCM
Vectors Research Management's Q2 2024 Portfolio in Review
As of Q2 2024, Vectors Research Management held 136 positions worth $326M, down 8% from $354M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Vectors Research Management withdrew a net $29.3M in Q2 2024, closing 9 positions and reducing 74 holdings. Its most notable exit was DexCom, an estimated $1.72M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.5% a quarter earlier, followed by Industrials and Energy.
Against the trend, Vectors Research Management opened a new position in iShares 3-7 Year Treasury Bond ETF worth $1.2M.
- Vectors Research Management's largest Q2 2024 buy was iShares 3-7 Year Treasury Bond ETF: 10,373 shares worth $1.2M.
- Vectors Research Management added most to State Street Consumer Staples Select Sector SPDR ETF in Q2 2024, an estimated $2M increase.
- Vectors Research Management's biggest Q2 2024 reduction was Vanguard Short-Term Inflation-Protected Securities Index Fund, cutting an estimated $7.76M.
- Vectors Research Management fully exited DexCom in Q2 2024, selling an estimated $1.72M.
- Vectors Research Management's ten largest holdings make up 40% of its $326M portfolio in Q2 2024.
- Vectors Research Management opened 4 new positions and closed 9 in Q2 2024.
- Vectors Research Management's portfolio value fell 8% quarter-over-quarter to $326M.
Based on Vectors Research Management's 13F filing for Q2 2024, filed 9 Aug 2024.